This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Kelli-Ann Monaco: Innovator in Cancer Treatment
Introduction
Kelli-Ann Monaco is a prominent inventor based in Medford, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical combinations.
Latest Patents
Kelli-Ann Monaco holds 1 patent for her invention titled "Combinations of MDM2 inhibitors with inhibitors of ERK for treating cancers." This invention relates to a pharmaceutical combination comprising an MDM2 inhibitor and an ERK inhibitor, aimed at treating various cancers. The patent outlines the uses of this combination for preparing a medicament, methods of treating cancer in subjects, and the formulation of pharmaceutical compositions.
Career Highlights
Kelli-Ann Monaco is associated with Novartis AG, a leading global healthcare company. Her work focuses on developing innovative solutions for cancer treatment, showcasing her commitment to advancing medical science.
Collaborations
Throughout her career, Kelli-Ann has collaborated with notable professionals in her field, including Giordano Caponigro and Ensar Halilovic. These collaborations have contributed to her success and the advancement of her research.
Conclusion
Kelli-Ann Monaco is a trailblazer in the field of cancer treatment, with her innovative patent reflecting her dedication to improving patient outcomes. Her work continues to inspire advancements in medical research and pharmaceutical development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile